Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125636661 | 12563666 | 1 | I | 201605 | 20160518 | 20160715 | 20160715 | PER | US-ASTRAZENECA-2016SE54700 | ASTRAZENECA | 711.00 | MON | F | Y | 88.50000 | KG | 20160716 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125636661 | 12563666 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 UG, 2 PUFFS TWICE DAILY | 21929 | BID | |||||||||
| 125636661 | 12563666 | 2 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2.0DF AS REQUIRED | 0 | 2 | DF | ||||||||
| 125636661 | 12563666 | 3 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | EVERY DAY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125636661 | 12563666 | 1 | Asthma |
| 125636661 | 12563666 | 2 | Inhalation therapy |
| 125636661 | 12563666 | 3 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125636661 | 12563666 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125636661 | 12563666 | 1 | 20160512 | 0 |